C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/1994
12/08/1994	WO1994028152A1 Defective adenoviruses and corresponding complementation lines
12/08/1994	WO1994028151A1 Gene therapy for haemophilia
12/08/1994	WO1994028149A1 Method of improving the quality of stored potatoes
12/08/1994	WO1994028144A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
12/08/1994	WO1994028143A1 Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
12/08/1994	WO1994028142A1 Putrescine n-methyltransferase, recombinant dna molecules encoding putrescine n-methyltransferase, and transgenic tobacco plants with decreased alkaloid content
12/08/1994	WO1994028141A1 Regulation of plant growth
12/08/1994	WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028128A1 Test and model for polycystic ovary syndrome and male pattern baldness
12/08/1994	WO1994028126A2 Phenylalanine-free protein and dna coding therefor
12/08/1994	WO1994028125A2 Dna encoding prostaglandin receptor ep1
12/08/1994	WO1994028122A1 Transgenic mammals lacking expression of particular cd45 isoforms
12/08/1994	WO1994028119A1 Novel process and apparatus
12/08/1994	WO1994028116A1 Nucleic acid encoding amp-activated protein kinase
12/08/1994	WO1994028113A1 Immortalization of denditric cells with v-myc oncogene
12/08/1994	WO1994028025A1 Methods and compositions for inhibiting cd14 mediated cell activation
12/08/1994	WO1994028023A1 Cell surface protein expressed on human cortical thymocyte and their use
12/08/1994	WO1994028019A1 Human calcium sensor
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994027698A2 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations
12/08/1994	WO1994027637A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
12/08/1994	WO1994027633A1 Bandage for continuous application of biologicals
12/08/1994	WO1994027622A1 Surrogate tolerogenesis for the development of tolerance to xenografts
12/08/1994	WO1994027556A2 Animal model for hepatitis virus infection
12/08/1994	WO1994027428A1 Post-transcriptional gene regulation by trace minerals
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994024163A3 Bispecific antigen-binding molecules
12/08/1994	CA2698716A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
12/08/1994	CA2168686A1 Process for growing a virus
12/08/1994	CA2164102A1 Immortalization of denditric cells with v-myc oncogene
12/08/1994	CA2163620A1 Method for selection of biologically active peptide sequences
12/08/1994	CA2163549A1 Process for screening substances having a modulating effect on any interleukin-5 receptor mediated cellular signal transmission pathway
12/08/1994	CA2163427A1 Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
12/08/1994	CA2163422A1 Antibodies specific for dcc gene product
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/08/1994	CA2163013A1 Human calcium sensor
12/08/1994	CA2162383A1 Method of improving the quality of stored potatoes
12/08/1994	CA2161979A1 Cloning, expression and uses of dorsalin-1
12/08/1994	CA2161015A1 Transgenic mammals lacking expression of particular cd45 isoforms
12/08/1994	CA2140455A1 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations
12/07/1994	EP0627487A2 Ligands for FLT3 receptors
12/07/1994	EP0627005A1 Ibv spike protein (2)
12/07/1994	EP0627002A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4
12/07/1994	EP0626998A1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna
12/07/1994	EP0626852A1 Method for making universal donor cells
12/07/1994	EP0626805A1 Protective effects of mutated superantigens
12/07/1994	EP0590066A4 Method for inducing human myocardial cell proliferation.
12/07/1994	EP0542830A4 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal
12/07/1994	EP0210189B1 Recombinant alveolar surfactant protein
12/06/1994	US5371206 DNA encoding chimeric fibroblast growth factors
12/06/1994	US5371205 PDGF α receptor
12/06/1994	US5371089 Method and composition for ameliorating the adverse effects of aging
12/06/1994	US5371010 Method for growing eukaryotic cells using soft agar assay and kit
12/06/1994	US5371009 Enhancers
12/06/1994	US5370868 Therapeutic use of vitaletheine modulators in neoplasia
12/01/1994	DE4316376A1 Method for the continuous cultivation of suspended cells without walls
11/1994
11/30/1994	EP0626450A2 Ubiquitin conjugating enzyme (E2) fusion proteins
11/30/1994	EP0626390A1 Humanised antibodies
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626012A1 Homogenotization of gene-targeting events
11/30/1994	EP0597964A4 Proliferation of hepatocyte precursors.
11/30/1994	EP0594725A4 Yolk sac stem cells.
11/30/1994	EP0509008B1 Biomass for the production of viruses/virus antigens
11/30/1994	EP0491733B1 Somatic embryogenesis of squash
11/30/1994	EP0383804B1 Generation of neural precursor cell lines
11/29/1994	US5369023 Method of purifying putrescine n-methyltransferase from tobacco plant extract with an anion exchange medium
11/29/1994	US5369012 Method of making a membrane having hydrophilic and hydrophobic surfaces for adhering cells or antibodies by using atomic oxygen or hydroxyl radicals
11/29/1994	US5369010 Antibodies specific to antigens for detection in human cells for matching donor organs to recipients and for rhumatoid arthritis
11/29/1994	CA1333264C Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi
11/24/1994	WO1994026923A1 Method for recombinant production of biologically active polypeptides
11/24/1994	WO1994026913A2 Marker gene
11/24/1994	WO1994026909A1 Herbicide resistant plants
11/24/1994	WO1994026908A1 Cho cell sialidase by recombinant dna technology
11/24/1994	WO1994026906A2 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE
11/24/1994	WO1994026905A1 Immortalized human cell lines containing exogenous cytochrome p450 genes
11/24/1994	WO1994026904A1 Hepatitis b virus mutants, reagents and methods for detection
11/24/1994	WO1994026894A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
11/24/1994	WO1994026893A1 Bmp-10 compositions
11/24/1994	WO1994026892A1 Bmp-11 compositions
11/24/1994	WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	WO1994026889A2 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
11/24/1994	WO1994026887A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/24/1994	WO1994026884A1 Embryonic stem cells for making chimeric and transgenic ungulates
11/24/1994	WO1994026877A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	WO1994026876A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
11/24/1994	WO1994026875A1 New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
11/24/1994	WO1994026872A1 Assessment of bone cell activity
11/24/1994	WO1994026322A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026305A1 Hiv immunogenic complexes
11/24/1994	WO1994026304A1 Otitis media vaccine
11/24/1994	WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases
11/24/1994	WO1994026283A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
11/24/1994	WO1994026100A1 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
11/24/1994	WO1994023035A3 Recombinant timothy grass pollen allergen phl p ii
11/24/1994	WO1994023034A3 Variant insulin-like growth factor I receptor subunits and methods for use thereof
11/24/1994	WO1994019464A3 Human dna sequence encoding a kidney atp-dependent potassium channel
11/24/1994	WO1994016073A3 Methods and reagents for inhibiting furin endoprotease
11/24/1994	CA2555020A1 Inhibition of migration of inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity

1 ... 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 ... 1827